Fulminant Giant Cell Myocarditis Requiring Bridge With Mechanical Circulatory Support to Heart Transplantation. [PDF]
JACC Case Rep, 2022 Giant cell myocarditis is a rare cause of cardiogenic shock requiring a high index of suspicion, rapid immunosuppressive therapy, and mechanical circulatory support.
Brailovsky Y +6 more
europepmc +2 more sources
Late gadolinium enhancement characteristics in giant cell myocarditis [PDF]
ESC Heart Failure, 2021 Aims This study aims to demonstrate the characteristics of late gadolinium enhancement (LGE) assessed by cardiovascular magnetic resonance (CMR) imaging in patients with giant cell myocarditis (GCM).
Shujuan Yang +6 more
doaj +2 more sources
Fulminant Giant Cell Myocarditis vs. Lymphocytic Myocarditis: A Comparison of Their Clinical Characteristics, Treatments, and Outcomes [PDF]
Frontiers in Cardiovascular Medicine, 2021 Objectives: Fulminant myocarditis (FM) is a rapidly progressive and frequently fatal form of myocarditis that has been difficult to classify. This study aims to compare the clinical characteristics, treatments and outcomes in patients with fulminant ...
Yuxiao Hu +16 more
doaj +2 more sources
Giant cell myocarditis in an older patient – reassessing the threshold for endomyocardial biopsy [PDF]
ESC Heart Failure, 2020 Giant cell myocarditis is a rare form of autoimmune myocarditis with high morbidity and mortality that affects mainly middle‐aged adults. We report a case study of a 70‐year‐old man on chronic immunosuppression who presented with sustained ventricular ...
Milan Dusík +8 more
doaj +2 more sources
Acquired myasthenia gravis with concurrent polymyositis and myocarditis secondary to a thymoma in a dog [PDF]
Open Veterinary Journal, 2021 Background: Canine thymomas are associated with multiple paraneoplastic syndromes, among which myasthenia gravis is the most common. Acquired myasthenia gravis is an autoimmune disease characterized by the presence of antibodies against acetylcholine ...
Raffaella Perillo +5 more
doaj +1 more source
Cardiac Sarcoidosis and Giant Cell Myocarditis: Actually, 2 Ends of the Same Disease? [PDF]
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021 David H. Birnie +2 more
doaj +2 more sources
High-risk and low prevalence disease: Cardiac sarcoidosis and some of its mimics
International Journal of Cardiology: Heart & Vasculature, 2023 In this narrative review of cardiac sarcoidosis, based on a literature search using the terms “cardiac sarcoidosis”, “tuberculous myocarditis”, “Whipple’s disease and myocarditis”, and”idiopathic giant cell myocarditis”, I have defined cardiac ...
Oscar M.P. Jolobe
doaj +1 more source
Fatal Enterovirus-related Myocarditis in a Patient with Devic’s Syndrome Treated with Rituximab
Cardiac Failure Review, 2021 Enteroviruses are a frequent source of infection and among the most common central nervous system viral pathogens. Enteroviruses – in particular, the Coxsackie B viruses – are a known cause of myocarditis.
Ava Diarra +16 more
doaj +1 more source
JA Clinical Reports, 2016 Background Giant cell myocarditis, characterized by infiltration of multinucleated giant cells in the myocardium, is a rare type of myocarditis. It often progresses rapidly into fulminant heart failure and indicates a poor prognosis.
Yusuke Takei +5 more
doaj +1 more source
Giant cell myocarditis masquerading as orbital myositis with a rapid, fulminant course necessitating mechanical support and heart transplantation. [PDF]
, 2017 Giant cell myocarditis (GCM), a rapidly progressive inflammation of the myocardium, is associated with fulminant heart failure, refractory ventricular arrhythmias, and conduction system abnormalities.
Aksoy, Olcay +5 more
core +1 more source